Drug Trial Radar · NCT00251134
OMEGA-Study: Effect of Omega 3-Fatty Acids on the Reduction of Sudden Cardiac Death After Myocardial Infarction
Last checked: Nov 20, 2026Latest source record: Sep 12, 2008 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
3,800
Actual
Start
Oct 2003
Primary completion
Jun 2008
Study completion Sep 2008
Sponsor
- Lead sponsor
- Stiftung Institut fuer HerzinfarktforschungAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Trommsdorff GmbH & Co. KG; Pronova BioPharma
- First posted
- Nov 9, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Cardiovascular disease (CVD) is the leading cause of death in North America and Europe. The major cause of CVD is atherosclerosis like coronary artery disease (CAD). The results of recent trials hint that the course of CAD may be positively influenced by an increased intake of omega 3-fatty acids. The OMEGA-Trial analyses this effect in subjects who suffered an acute myocardial infarction. They are divided into two groups, both receiving standard post-infarction therapy. The subjects of one group additionally receive 1 gram of omega 3-fatty acids daily for a time-period of 12 months, while the subjects in the second group receive 1 gram olive-oil as placebo. Within the period of 12 months all events are reported and used to analyse the efficacy and safety of the additional therapy with omega 3-fatty acids.
Conditions
- Myocardial Infarction
Interventions
Zodin (drug)Drug
1 gram omega-3-acid ethyl esters 90 daily for a period of 12 months
Olive oil (placebo)Drug
1 gram olive oil daily for a period of 12 months
Primary outcomes
What the sponsor says the trial is designed to measure.
- Sudden cardiac deathTime frame: 12 months
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
Johanniter-Krankenhaus Rheinhausen
Duisburg, Germany
Elisabeth-Krankenhaus
Essen, Germany
Staedt. Kliniken Frankfurt/Main-Hoechst
Frankfurt am Main, Germany
Klinikum Fuerth
Fürth, Germany
Universitaetsklinikum Heidelberg
Heidelberg, Germany
Klinikum Ingolstadt
Ingolstadt, Germany
Klinikum Neustadt
Neustadt/Aisch, Germany
Elisabeth-Krankenhaus
Recklinghausen, Germany
Marienkrankenhaus
Soest, Germany
Klinikum der Stadt Ludwigshafen gGmbH
Ludwigshafen am Rhein, Rhineland-Palatinate, Germany
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.